Skip to main content

Press

SNO Guidelines Endorsement 

The Society for Neuro-Oncology recognizes that other professional organizations may from time to time develop guidelines that would benefit the membership of SNO. The SNO Guidelines Committee is committed to systematically evaluating these documents and disseminating these documents to its membership as appropriate.

SNO will consider endorsement of clinical practice guidelines initiated by other professional organizations when relevant and appropriate to the mission and interests of SNO and its membership.

To read the SNO Guidelines Endorsement criteria, click here.

SNO has officially endorsed the following guidelines:

Brain tumor-related epilepsy management: A Society for Neuro-oncology (SNO) consensus review on current management
Published September 12, 2023. To view consensus paper, click here.  

Isocitrate dehydrogenase (IDH) mutant gliomas: A Society for Neuro-Oncology (SNO) consensus review on diagnosis, management, and future directions
Published October 12, 2022. To view consensus paper, click here.

Radiation Therapy for IDH-Mutant Grade 2 and Grade 3 Diffuse Glioma: An ASTRO Clinical Practice Guideline
Published September 1, 2022. TO view the ASTRO manuscript, click here.

EANO, EURACAN, SNO Guidelines on circumscribed astrocytic gliomas, glioneuronal, and neuronal tumors 
Published August 1, 2022 Neuro-Oncology. To view the publication, click here.

Brain metastases: A Society for Neuro-Oncology (SNO) consensus review on current management and future directions 
Published June 28, 2022. To view consensus paper, click here.  

Radiation Therapy for Brain Metastases Guideline

Published May 6, 2022. To view the ASTRO manuscript, click here.

Therapy for Diffuse Astrocytic and Oligodendroglial Tumors in Adults:  ASCO-SNO Guidelines
Published December 22, 2021 Neuro-Oncology.  To view the publication, click here

Treatment for Brain Metastases:  ASCO/SNO/ASTRO Guidelines
Published December 21, 2021 Neuro-Oncology.  To view the publication, click here.   

EANO, SNO and Euracan consensus review on the current management and future development of intracranial germ cell tumors in adolescents and young adults
Published November 1, 2021 Journal of Clinical Oncology. To view the publication, click here.

Management of Immune-Related Adverse Events in Patients Treated With Immune Checkpoint Inhibitor Therapy: ASCO Guideline Update
Published November 1, 2021 Journal of Clinical Oncology. To view the publication, click here.

Management of Immune-Related Adverse Events in Patients Treated With Chimeric Antigen Receptor T-Cell Therapy: ASCO Guideline
Published November 1, 2021 Journal of Clinical Oncology. To view the publication, click here.

SNO and EANO practice guideline update: Anticonvulsant prophylaxis in patients with newly diagnosed brain tumors 
To view the update, click here

Consensus recommendations for a dynamic susceptibility contrast MRI protocol for use in high-grade gliomas  
Endorsed 6/18/21. To view the publication, click here.  

SNO/EANO consensus review Glioblastoma in adults: a Society for Neuro-Oncology (SNO) and European Society of Neuro-Oncology (EANO) consensus review on current management and future directions. 
Published in Neuro-Oncology January 20, 2021.  To view consensus review, click here.

Radiation therapy for glioblastoma: Executive summary of an American Society for Radiation Oncology Evidence-Based Clinical Practice Guideline
To view the ASTRO manuscript, click here.

Neuro-Oncology Patient Survivorship Care Plan
To view the Care Plan, click here.

Neuro-Oncology Quality Measurement Set
Published in Neuro-Oncology March 2, 2018.  To view the publication, click here.